Your browser doesn't support javascript.
loading
Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99.
Pagani, O; Klingbiel, D; Ruhstaller, T; Nolè, F; Eppenberger, S; Oehlschlegel, C; Bernhard, J; Brauchli, P; Hess, D; Mamot, C; Munzone, E; Pestalozzi, B; Rabaglio, M; Aebi, S; Ribi, K; Rochlitz, C; Rothgiesser, K; Thürlimann, B; von Moos, R; Zaman, K; Goldhirsch, A.
Afiliação
  • Pagani O; Institute of Oncology and Breast Unit of Southern Switzerland, Bellinzona.
  • Klingbiel D; Swiss Group for Clinical Cancer Research, Coordinating Center, Bern.
  • Ruhstaller T; Breast Center, St. Gallen, Switzerland.
  • Nolè F; European Institute of Oncology, Milano, Italy.
  • Eppenberger S; Molecular Pathology, University Hospital, Basel.
  • Oehlschlegel C; Pathology, Kantonsspital, San Gallen.
  • Bernhard J; International Breast Cancer Study Group Coordinating Center, Bern.
  • Brauchli P; Swiss Group for Clinical Cancer Research, Coordinating Center, Bern.
  • Hess D; Department of Internal Medicine, Kantonsspital, St.Gallen.
  • Mamot C; Oncology, Kantonsspital, Aarau, Switzerland.
  • Munzone E; European Institute of Oncology, Milano, Italy.
  • Pestalozzi B; Oncology, University Hospital, Zurich.
  • Rabaglio M; Breast Unit, Inselspital, Bern.
  • Aebi S; Medical Oncology, Inselspital Bern, now at Luzerner Kantonsspital.
  • Ribi K; International Breast Cancer Study Group Coordinating Center, Bern.
  • Rochlitz C; Oncology, University Hospital, Basel.
  • Rothgiesser K; Swiss Group for Clinical Cancer Research, Coordinating Center, Bern.
  • Thürlimann B; Breast Center, St.Gallen.
  • von Moos R; Department of Medicine, Kantonsspital, Chur.
  • Zaman K; Breast Centre, University Hospital, Lausanne, Switzerland.
  • Goldhirsch A; European Institute of Oncology, Milano, Italy.
Ann Oncol ; 28(2): 305-312, 2017 02 01.
Article em En | MEDLINE | ID: mdl-27998961

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_breast_cancer / 6_other_malignant_neoplasms Assunto principal: Neoplasias Ósseas / Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Prognostic_studies Aspecto: Patient_preference Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_breast_cancer / 6_other_malignant_neoplasms Assunto principal: Neoplasias Ósseas / Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Prognostic_studies Aspecto: Patient_preference Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article
...